World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
43
Citations
7143
World Ranking
5258
National Ranking
131

Karin J. Metzner publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Karin J. Metzner sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 225 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Karin J. Metzner D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Karin J. Metzner sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 43 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Karin J. Metzner is affiliated with the University of Zurich in Switzerland. Their research expertise spans medicine and immunology and microbiology, with a particular focus on infectious diseases and virology. Their work notably addresses HIV research and treatment, including drug development, interventions, and HIV-related health complications.

The scientist has contributed extensively to several key areas of study, including:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • Immune Cell Function and Interaction
  • Hepatitis C virus research
  • CRISPR and Genetic Engineering

Scientific publication venues where Karin J. Metzner has frequently published include:

  • The Journal of Infectious Diseases (16 publications)
  • Clinical Infectious Diseases (13 publications)
  • Open Forum Infectious Diseases (13 publications)
  • Viruses (8 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (8 publications)

Their recent published papers demonstrate a concentration on viral genetics, HIV epidemiology, and clinical impacts of antiretroviral therapy. Selected recent papers include:

  • Cohort Profile Update: The Swiss HIV Cohort Study (SHCS), 2021, International Journal of Epidemiology
  • V-pipe: a computational pipeline for assessing viral genetic diversity from high-throughput data, 2021, Bioinformatics
  • A highly virulent variant of HIV-1 circulating in the Netherlands, 2022, Science
  • Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV, 2022, Zurich Open Repository and Archive (University of Zurich)
  • Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy, 2023, Clinical Infectious Diseases

Karin J. Metzner collaborates regularly with several researchers, indicative of a broad and active research network. Frequent co-authors include:

  • Huldrych F. Günthard (122 co-authored publications)
  • Enos Bernasconi (105 co-authored publications)
  • Roger D. Kouyos (105 co-authored publications)
  • Matthias Cavassini (96 co-authored publications)
  • Dominique L. Braun (91 co-authored publications)

Their body of work contributes to a deeper understanding of infectious disease dynamics, with a particular emphasis on HIV epidemiology, antiviral resistance, and the immunological consequences of infection and treatment.

Best Publications

  • HIV suppression by interleukin-16.

    Michael Baier;Albrecht Werner;Norbert Bannert;Karin Metzner

  • Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

    Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia

  • Minority Quasispecies of Drug-Resistant HIV-1 That Lead to Early Therapy Failure in Treatment-Naive and -Adherent Patients

    Karin J. Metzner;Stefano G. Giulieri;Stefanie A. Knoepfel;Pia Rauch

  • Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data

    Niko Beerenwinkel;Niko Beerenwinkel;Huldrych F. Günthard;Volker Roth;Karin J. Metzner

  • Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

    Karin J. Metzner;Xia Jin;Fred V. Lee;Agegnehu Gettie

  • Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.

    Nadine Bachmann;Chantal von Siebenthal;Valentina Vongrad;Teja Turk

  • Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions

    Karin J. Metzner;Karin J. Metzner;Sebastian Bonhoeffer;Marek Fischer;Rose Karanicolas

  • Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.

    Karin J Metzner;Pia Rauch;Hauke Walter;Christoph Boesecke

  • Full-length haplotype reconstruction to infer the structure of heterogeneous virus populations

    Francesca Di Giallonardo;Armin Töpfer;Melanie Rey;Sandhya Prabhakaran

  • Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

    Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  • Molecular cloning, expression and characterization of Pru a 1, the major cherry allergen

    S. Scheurer;K. Metzner;D. Haustein;S. Vieths

  • Blinded, Multicenter Comparison of Methods To Detect a Drug-Resistant Mutant of Human Immunodeficiency Virus Type 1 at Low Frequency

    Elias K. Halvas;Grace M. Aldrovandi;Peter Balfe;Ingrid A. Beck

  • Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo

    Satish K. Pillai;Mohamed Abdel-Mohsen;John Guatelli;Mark Skasko

  • Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).

    Alexandra U Scherrer;Anna Traytel;Dominique L Braun;Alexandra Calmy

  • Profound Depletion of HIV-1 Transcription in Patients Initiating Antiretroviral Therapy during Acute Infection

    Adrian Schmid;Sara Gianella;Viktor von Wyl;Karin J. Metzner

  • Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection

    Philip Rieder;Beda Joos;Alexandra U. Scherrer;Herbert Kuster

  • Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study

    Gilles Wandeler;Thomas Gsponer;Florian Bihl;Enos Bernasconi

  • V-pipe: a computational pipeline for assessing viral genetic diversity from high-throughput data.

    Susana Posada-Céspedes;Susana Posada-Céspedes;David Seifert;David Seifert;Ivan Topolsky;Ivan Topolsky;Kim Philipp Jablonski;Kim Philipp Jablonski

  • Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

    Sara M. Drescher;Viktor von Wyl;Wan-Lin Yang;Jürg Böni

  • Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study

    Barbara Hasse;Martin Iff;Bruno Ledergerber;Alexandra Calmy

  • Efficient suppression of minority drug resistant HIV type 1 (HIV 1) variants present at primary HIV 1 infection by ritonavir boosted protease inhibitor-containing antiretroviral therapy.

    Karin J. Metzner;Karin J. Metzner;Pia Rauch;Viktor von Wyl;Christine Leemann

  • Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012

    Wan-Lin Yang;Roger Kouyos;Alexandra U. Scherrer;Jürg Böni

Frequent Co-Authors

Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Jürg Böni
Jürg Böni University of Zurich
Roger D. Kouyos
Roger D. Kouyos University of Zurich
Matthias Cavassini
Matthias Cavassini University of Lausanne
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Sabine Yerly
Sabine Yerly University of Geneva
Thomas Klimkait
Thomas Klimkait University of Basel
Andri Rauch
Andri Rauch University of Bern
Rainer Weber
Rainer Weber University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in extending their microbiology background, many online healthcare programs offer flexible options to gain specialized medical knowledge. These programs can complement a microbiology degree and open doors to careers in healthcare and research.

Public health is a natural extension for microbiology graduates, and exploring easy mph online programs can make continuing education more accessible. These programs help develop skills in epidemiology, disease prevention, and health policy—essential for combating infectious diseases.

Career pathways can also branch into unique roles like becoming a child life specialist. This career involves supporting children and families in medical settings, leveraging scientific knowledge alongside psychosocial expertise.

Finally, it’s important to recognize that inclusive education opportunities exist, including online colleges that accept felons. This ensures individuals with diverse backgrounds can pursue degrees that lead to meaningful careers in microbiology and allied fields.

Best Scientists Citing Karin J. Metzner

Trending Scientists

Recently Published Articles